Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Hyman Insider Profile
4 Followers
David Hyman, Chief Financial Officer at Rakovina Therapeutics Inc, holds 40.00K shares in Medicenna Therapeutics Corp (Ticker: TSE:MDNA), holds 315.00K shares in Rakovina Therapeutics Inc (Ticker: TSE:RKV). Most recently, David Hyman Bought ― shares of Medicenna Therapeutics Corp on Jan 11, 2025 for an estimated value of 29.00K.
David Hyman Rakovina Therapeutics Inc (RKV)Chief Financial Officer
Rakovina Therapeutics Inc (RKV)
Chief Financial Officer
Ranked #79,067 out of 100,370 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-22.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Hyman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jan 11, 2025 - Today
Return:-2.10%
The most profitable trade made by David Hyman
David Hyman's Trading History
Rakovina Therapeutics Inc
Jan 20, 2023
Chief Financial Officer
Informative Buy
10.14K
C$63.00K
Medicenna Therapeutics Corp
Jan 11, 2025
Chief Financial Officer
Informative Buy
29.00K
C$52.80K
List of latest transactions for each holding click on a transaction to see David Hyman's performance on stock
You May Also Like
David Hyman insider profile FAQ
What is the percentage of profitable transactions made by David Hyman?
The percentage of profitable transactions made by David Hyman is 0%.
What is the average return per transaction made by David Hyman?
The average return per transaction made by David Hyman is -22.90%.
What stocks does David Hyman hold?
David Hyman holds: TSE:RKV, TSE:MDNA stocks.
What was David Hyman’s latest transaction?
David Hyman latest transaction was an Informative Buy of C$29.00K.
What was David Hyman's most profitable transaction?
David Hyman’s most profitable transaction was an Informative Buy of TSE:MDNA stock on January 11, 2025. The return on the trade was -2.10%.
What is David Hyman's role in Rakovina Therapeutics Inc?
David Hyman's role in Rakovina Therapeutics Inc is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.